A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Neuroendocrine Tumors
Related studies linked through entity extraction aliases.
Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Non Interventional Post Marketing Programme in Neuroendocrine Tumours
- Status
- COMPLETED
- Phase
- N/A
11C-Acetate PET/CT Non-FDG-Avid Tumors
- Status
- UNKNOWN
- Phase
- N/A
Clinical and Pathologic Studies in Neuroendocrine Tumors
- Status
- WITHDRAWN
- Phase
- N/A
Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Lithium for Low-Grade Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Pemetrexed in Patients With Advanced Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion
- Status
- TERMINATED
- Phase
- PHASE3
Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Treatment With SU11248 in Patients With Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
EPO906 in Carcinoid and Other Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE3